this piece corresponds to the legacy myPDB login in the form of a bootstrap modal, will likely retire-->

Chemical Component Summary

NameFLAVIN-ADENINE DINUCLEOTIDE
Identifiers[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl [[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-benzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentoxy]-hydroxy-phosphoryl] hydrogen phosphate
FormulaC27 H33 N9 O15 P2
Molecular Weight785.55 g/mol
TypeNON-POLYMER
Isomeric SMILESCc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n3cnc4c(N)ncnc34)c2cc1C
InChIInChI=1S/C27H33N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1
InChIKeyVWWQXMAJTJZDQX-UYBVJOGSSA-N

Chemical Details

Formal Charge0
Atom Count86
Chiral Atom Count9
Chiral AtomsC1B,C2',C2B,C3',C3B,C4',C4B,P,PA
Bond Count91
Aromatic Bond Count16
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB03147 Different stereochemistry
NameFlavin adenine dinucleotide
Groupsapproved
DescriptionA condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. (Lehninger, Principles of Biochemistry, 1982, p972) Flavin adenine dinucleotide is approved for use in Japan under the trade name Adeflavin as an ophthalmic treatment for vitamin B2 deficiency.
Synonyms
  • Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine
  • Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]
  • FAD
  • Flavin adenine dinucleotide
  • FLAVIN-adenine dinucleotide
SaltsFlavin adenine dinucleotide sodium
Brand Names
  • Enbrace Hr
  • Enlyte
  • Adeflavin
  • Flaziren
Affected OrganismHumans and other mammals
IndicationUsed to treat eye diseases caused by vitamin B2 deficiency, such as keratitis and blepharitis.
Route of administrationOral
Categories
  • Adenine Nucleotides
  • Biological Factors
  • Carbohydrates
  • Coenzymes
  • Enzymes and Coenzymes
CAS number146-14-5

Drug Targets

NameSequence SearchPharmacological ActionActions
Sulfite reductase [NADPH] flavoprotein alpha-componentMTTQVPPSALLPLNPEQLARLQAATTDLTPTQLAWVSGYFWGVLNQQPAA...unknown
NADPH:adrenodoxin oxidoreductase, mitochondrialMASRCWRWWGWSAWPRTRLPPAGSTPSFCHHFSTQEKTPQICVVGSGPAG...unknown
5,10-methylenetetrahydrofolate reductaseMSFFHASQRDALNQSLAEVQGQINVSFEFFPPRTSEMEQTLWNSIDRLSS...unknown
Glutathione reductaseMTKHYDYIAIGGGSGGIASINRAAMYGQKCALIEAKELGGTCVNVGCVPK...unknown
Amine oxidase [flavin-containing] BMSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQK...unknown
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682